S5 - General Neurology: Pathogenesis, Modulation, and Biomarkers of Complex Neurological Disorders

Event Time: Sunday April 23, 2017 1:00 pm to 3:00 pm
Topic(s): General Neurology
Director(s):
Description: A group of abstracts covering a similar topic presented in an oral format. Presentations are eight minutes in length with four minutes of question and answer. Each session concludes with 25 minutes of a discussant bringing additional context to one or more of the abstracts.
Completion Message:
CME Credits: 2
Core Competencies:

Abstract Presenters

Start Time Pub. Title Presenter
1:00 PM 001 Impact of NEOD001 on Neuropathy in Patients With Light Chain Amyloidosis and Persistent Organ Dysfunction: Results From the Expansion Phase of a Phase 1/2 Study Michaela Liedtke
Disclosure:
Dr. Liedtke has received personal compensation for activities with Prothena, Amgen, Takeda, and Pfizer as a consultant or advisor. Dr. Liedtke has received research support from Prothena, Amgen, Takeda, Pfizer, Celgene, and Novartis.

1:12 PM 002 Corticokinematic coherence is decreased in patients with Friedreich Ataxia and correlates with GAA1 expansion Gilles Naeije
Disclosure:
Dr. Naeije has nothing to disclose.

1:24 PM 003 Long-Term Risk of Seizures in Survivors of Sepsis Michael Reznik, MD
Disclosure:
Dr. Reznik has nothing to disclose.

1:36 PM 004 Impact of Neurological Magnetic Resonance Imaging in Non-Approved Cardiac Devices Lina Ya'qoub
Disclosure:
Dr. Ya'qoub has nothing to disclose.

1:48 PM 005 Resting cerebral perfusion impairment in Type 2 Diabetes Weiying Dai
Disclosure:
Dr. Dai has nothing to disclose.

2:00 PM 006 Clinical features of post-vaccination Guillain-Barrè Syndrome (GBS) in the Republic of Korea Bum Chun Suh
Disclosure:
Dr. Suh has nothing to disclose.

2:12 PM 007 Specific human antisense oligonucleotide (ASO) targeting TGF-ßRII rescues proliferation of TGF-ß arrested human neuronal progenitor cells (ReNcell CX) Sabrina Kuespert, PhD
Disclosure:
Dr. Kuespert has nothing to disclose.

2:24 PM 008 Glia maturation factor inhibits mitochondrial biogenesis, increase oxidative stress and apoptotic cell death in dopaminergic neurons Govindhasamy Pushpavathi Selvakumar
Disclosure:
Dr. Selvakumar has nothing to disclose.

Register Now

Related Courses